ステントリトリーバーのパイプライン - 開発段階、セグメント、地域と国、規制経路、主要企業（2024年版）

当レポートでは、ステントリトリーバーのパイプライン製品について調査分析し、さまざまな開発段階にある製品の比較分析や、進行中の臨床試験のデータを含む、包括的な情報を提供しています。

目次

第1章 目次

第2章 イントロダクション

第3章 開発中の製品

• ステントリトリーバー - パイプライン製品：開発段階別
• ステントリトリーバー - パイプライン製品：地域別
• ステントリトリーバー - パイプライン製品：規制経路別
• ステントリトリーバー - パイプライン製品：推定承認日別
• ステントリトリーバー - 進行中の臨床試験

第4章 ステントリトリーバー - 各社の開発中のパイプライン製品

• ステントリトリーバー企業 - パイプライン製品：開発段階別
• ステントリトリーバー - パイプライン製品：開発段階別

第5章 ステントリトリーバーの企業と製品の概要

• Amnis Therapeutics Ltd：企業の概要
  • Amnis Therapeutics Ltd：パイプライン製品と進行中の臨床試験の概要
• Biomedical Solutions Inc：企業の概要
  • Biomedical Solutions Inc：パイプライン製品と進行中の臨床試験の概要
• Capital Medical University：企業の概要
  • Capital Medical University：パイプライン製品と進行中の臨床試験の概要
• HeMo Bioengineering Ltd：企業の概要
  • HeMo Bioengineering Ltd：パイプライン製品と進行中の臨床試験の概要
• Insera Therapeutics LLC：企業の概要
  • Insera Therapeutics LLC：パイプライン製品と進行中の臨床試験の概要
• Medtronic Plc：企業の概要
  • Medtronic Plc：パイプライン製品と進行中の臨床試験の概要
• MicroPort NeuroScientific Corp：企業の概要
  • MicroPort NeuroScientific Corp：パイプライン製品と進行中の臨床試験の概要
• MiVi Neuroscience Inc：企業の概要
  • MiVi Neuroscience Inc：パイプライン製品と進行中の臨床試験の概要
• Nanjing Kanite Medical Technology Co Ltd：企業の概要
  • Nanjing Kanite Medical Technology Co Ltd：パイプライン製品と進行中の臨床試験の概要
• NeuroVasc Technologies Inc：企業の概要
  • NeuroVasc Technologies Inc：パイプライン製品と進行中の臨床試験の概要
• OrbusNeich：企業の概要
  • OrbusNeich：パイプライン製品と進行中の臨床試験の概要
• Perflow Medical, Ltd.：企業の概要
  • Perflow Medical, Ltd.：パイプライン製品と進行中の臨床試験の概要
• Shanghai MicroPort Medical Group Co Ltd：企業の概要
  • Shanghai MicroPort Medical Group Co Ltd：パイプライン製品と進行中の臨床試験の概要
• SinoMedCare Biotech Co Ltd：企業の概要
  • SinoMedCare Biotech Co Ltd：パイプライン製品と進行中の臨床試験の概要
• Sree Chitra Tirunal Institute for Medical Sciences & Technology：企業の概要
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology：パイプライン製品と進行中の臨床試験の概要
• Triticum Medical Ltd.：企業の概要
  • Triticum Medical Ltd.：パイプライン製品と進行中の臨床試験の概要
• Vesalio LLC：企業の概要
  • Vesalio LLC：パイプライン製品と進行中の臨床試験の概要
• Zhejiang Kindly Medical Devices Co Ltd：企業の概要
  • Zhejiang Kindly Medical Devices Co Ltd：パイプライン製品と進行中の臨床試験の概要
• Zylox-Tonbridge Medical Technology Co Ltd：企業の概要
  • Zylox-Tonbridge Medical Technology Co Ltd：パイプライン製品と進行中の臨床試験の概要

第6章 ステントリトリーバー - 近年の発展

• 2024年9月4日：Rapid Medical、TIGERTRIEVER13を用いたDISTALS試験の中間安全性解析で中型血管閉塞の安全性に関する懸念はないと報告
• 2024年8月26日：Zylox-Tonbridge、2024年の中間決算で好調な業績を報告、大幅な成長と収益性を達成
• 2024年7月10日：Vesalio、Neva Net 5.5 MMの国際的な成功に続き、Neva Net 4.0 MMを発表
• 2024年5月14日：Rapid Medical、世界初のロボット血栓除去デバイスで虚血性脳卒中手術に成功
• 2024年2月5日：Wallabyphenox、Prost試験でエビデンスに基づく医療の新たなベンチマークを大胆に確立
• 2023年12月14日：Rapid Medical、血行再建デバイスの日本での承認を取得
• 2023年11月16日：Rapid MedicalのTIGERTRIEVERがICADを伴う困難な虚血性脳卒中患者に初回通過の成功をもたらす
• 2023年11月5日：phenox、pREset LITE血栓除去デバイスの追加510（K）承認を取得

第7章 付録

List of Tables

• Stent Retrievers - Pipeline Products by Stage of Development
• Stent Retrievers - Pipeline Products by Territory
• Stent Retrievers - Pipeline Products by Regulatory Path
• Stent Retrievers - Pipeline Products by Estimated Approval Date
• Stent Retrievers - Ongoing Clinical Trials
• Stent Retrievers Companies - Pipeline Products by Stage of Development
• Stent Retrievers - Pipeline Products by Stage of Development
• Glossary

List of Figures

• Stent Retrievers - Pipeline Products by Stage of Development
• Stent Retrievers - Pipeline Products by Territory
• Stent Retrievers - Pipeline Products by Regulatory Path
• Stent Retrievers - Pipeline Products by Estimated Approval Date
• Stent Retrievers - Ongoing Clinical Trials

GlobalData's Medical Devices sector report, "Stent Retrievers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Stent Retrievers pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Stent retrievers are deployed by a catheter that is threaded through the clot. Once the stent is fully deployed, the stent is retrieved with the clot attached.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the Stent Retrievers under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Stent Retrievers and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Stent Retrievers under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Stent Retrievers Overview

3 Products under Development

• 3.1 Stent Retrievers - Pipeline Products by Stage of Development
• 3.2 Stent Retrievers - Pipeline Products by Territory
• 3.3 Stent Retrievers - Pipeline Products by Regulatory Path
• 3.4 Stent Retrievers - Pipeline Products by Estimated Approval Date
• 3.5 Stent Retrievers - Ongoing Clinical Trials

4 Stent Retrievers - Pipeline Products under Development by Companies

• 4.1 Stent Retrievers Companies - Pipeline Products by Stage of Development
• 4.2 Stent Retrievers - Pipeline Products by Stage of Development

5 Stent Retrievers Companies and Product Overview

• 5.1 Amnis Therapeutics Ltd Company Overview
  • 5.1.1 Amnis Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.2 Biomedical Solutions Inc Company Overview
  • 5.2.1 Biomedical Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.3 Capital Medical University Company Overview
  • 5.3.1 Capital Medical University Pipeline Products & Ongoing Clinical Trials Overview
• 5.4 HeMo Bioengineering Ltd Company Overview
  • 5.4.1 HeMo Bioengineering Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.5 Insera Therapeutics LLC Company Overview
  • 5.5.1 Insera Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.6 Medtronic Plc Company Overview
  • 5.6.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
• 5.7 MicroPort NeuroScientific Corp Company Overview
  • 5.7.1 MicroPort NeuroScientific Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.8 MiVi Neuroscience Inc Company Overview
  • 5.8.1 MiVi Neuroscience Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.9 Nanjing Kanite Medical Technology Co Ltd Company Overview
  • 5.9.1 Nanjing Kanite Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.10 NeuroVasc Technologies Inc Company Overview
  • 5.10.1 NeuroVasc Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.11 OrbusNeich Company Overview
  • 5.11.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview
• 5.12 Perflow Medical, Ltd. Company Overview
  • 5.12.1 Perflow Medical, Ltd. Pipeline Products & Ongoing Clinical Trials Overview
• 5.13 Shanghai MicroPort Medical Group Co Ltd Company Overview
  • 5.13.1 Shanghai MicroPort Medical Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.14 SinoMedCare Biotech Co Ltd Company Overview
  • 5.14.1 SinoMedCare Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.15 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
  • 5.15.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
• 5.16 Triticum Medical Ltd. Company Overview
  • 5.16.1 Triticum Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
• 5.17 Vesalio LLC Company Overview
  • 5.17.1 Vesalio LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.18 Zhejiang Kindly Medical Devices Co Ltd Company Overview
  • 5.18.1 Zhejiang Kindly Medical Devices Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.19 Zylox-Tonbridge Medical Technology Co Ltd Company Overview
  • 5.19.1 Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

6 Stent Retrievers- Recent Developments

• 6.1 Sep 04, 2024: Rapid Medical Reports No Safety Concerns for Medium Vessel Occlusions in the Interim Safety Analysis of the DISTALS Study with TIGERTRIEVER13
• 6.2 Aug 26, 2024: Zylox-Tonbridge Reports Strong Interim Financial Results for 2024, Achieving Significant Growth and Profitability
• 6.3 Jul 10, 2024: Vesalio Introduces Neva Net 4.0 MM Following International Success of Neva Net 5.5 MM
• 6.4 May 14, 2024: Rapid Medical Completes Successful Ischemic Stroke Procedures with the World's First Robotic Thrombectomy Device
• 6.5 Feb 05, 2024: Wallabyphenox Boldly Sets New Benchmark in Evidence-Based Medicine with the Prost Trial
• 6.6 Dec 14, 2023: Rapid Medical receives Japanese approval for revascularisation device
• 6.7 Nov 16, 2023: Rapid Medical's TIGERTRIEVER Delivers First-Pass Success in Challenging Ischemic Stroke Patients with ICAD
• 6.8 Nov 05, 2023: phenox Receives Additional 510(K) Clearance for pREset LITE Thrombectomy Device

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us
• 7.4 Disclaimer